TrialBMC cancer2011

Phase I-II study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell cancer.

Charlotte M Huijts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.